|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
57,080,000 |
Market
Cap: |
149.55(M) |
Last
Volume: |
97,895 |
Avg
Vol: |
97,630 |
52
Week Range: |
$1.32 - $4.2 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 5.4 |
Insider 6 Months : 6.1 |
Insider 3/6 Months : 11.5 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
4,500 |
5,000 |
6,598 |
28,898 |
Total Buy Value |
$14,360 |
$15,253 |
$18,107 |
$54,541 |
Total People Bought |
3 |
4 |
4 |
5 |
Total Buy Transactions |
3 |
4 |
5 |
11 |
Total Shares Sold |
25,000 |
25,000 |
25,000 |
45,000 |
Total Sell Value |
$76,500 |
$76,500 |
$76,500 |
$118,240 |
Total People Sold |
1 |
1 |
1 |
2 |
Total Sell Transactions |
2 |
2 |
2 |
4 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
10x Capital Management, Llc |
10% Owner |
|
2016-09-30 |
4 |
A |
$1.13 |
$95,586 |
D/D |
84,589 |
3,425,498 |
|
- |
|
Czirr James C |
Director |
|
2016-06-30 |
4 |
A |
$1.47 |
$117,912 |
I/I |
80,212 |
3,340,909 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2016-06-30 |
4 |
A |
$1.47 |
$117,912 |
D/D |
80,212 |
3,340,909 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2016-04-20 |
4 |
S |
$1.59 |
$17,852 |
D/D |
(11,212) |
3,260,697 |
|
- |
|
Czirr James C |
Director |
|
2016-04-20 |
4 |
S |
$1.59 |
$17,852 |
I/I |
(11,212) |
3,260,697 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2016-04-19 |
4 |
S |
$1.70 |
$56,287 |
D/D |
(33,100) |
3,271,909 |
|
- |
|
Czirr James C |
Director |
|
2016-04-19 |
4 |
S |
$1.70 |
$56,287 |
I/I |
(33,100) |
3,271,909 |
|
- |
|
Greenberg Arthur |
Director |
|
2016-01-05 |
4 |
B |
$1.72 |
$2,866 |
D/D |
1,666 |
109,445 |
2.31 |
- |
|
Amelio Gilbert F |
Director |
|
2015-11-30 |
4 |
S |
$2.10 |
$210 |
D/D |
(100) |
119,961 |
|
- |
|
Traber Peter G |
President & CEO |
|
2015-08-12 |
4 |
B |
$2.00 |
$4,000 |
D/D |
2,000 |
107,333 |
2.73 |
- |
|
Freeman Kevin D |
Director |
|
2015-06-01 |
4 |
B |
$2.70 |
$5,624 |
I/I |
2,083 |
2,083 |
2.1 |
- |
|
Traber Peter G |
President & CEO |
|
2015-06-01 |
4 |
B |
$2.53 |
$10,120 |
D/D |
4,000 |
105,333 |
2.74 |
- |
|
Rubin Marc |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,768 |
48,581 |
|
- |
|
Amelio Gilbert F |
Director |
|
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,921 |
120,061 |
|
- |
|
Rubin Marc |
Director |
|
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
28,367 |
45,813 |
|
- |
|
Pressler Herman Paul |
Director |
|
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,483 |
36,767 |
|
- |
|
Mauldin John F |
Director |
|
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,483 |
42,669 |
|
- |
|
Prelack Steven |
Director |
|
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
93,141 |
107,189 |
|
- |
|
Freeman Kevin D |
Director |
|
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,531 |
27,643 |
|
- |
|
Martin Rod D |
Director |
|
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
26,395 |
202,089 |
|
- |
|
Omenn Gilbert S |
Director |
|
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,934 |
67,561 |
|
- |
|
Amelio Gilbert F |
Director |
|
2015-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,054 |
104,140 |
|
- |
|
Omenn Gilbert S |
Director |
|
2015-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,506 |
41,627 |
|
- |
|
Amelio Gilbert F |
Director |
|
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
103,086 |
|
- |
|
Rubin Marc |
Director |
|
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
17,446 |
|
- |
|
319 Records found
|
|
Page 12 of 13 |
|
|